Table 2.

Significantly altered lipoproteins. Both p-value and FDR comparisons are shown for unadjusted and adjusted data. Abbreviations; AD—Alzheimer’s disease, Con—Healthy control, FDR—False discovery rate, FC—Fold change, HDL—High-density lipoprotein, H1A2—HDL-1 Apo-A2, H2A2—HDL-2 Apo-A2, IDTG—IDL triglycerides, LDL–Low-density lipoprotein, LDTG—LDL triglycerides, L4TG—LDL-4 triglycerides, L5TG—LDL-5 triglycerides, L6TG—LDL-6 triglycerides, SD—Standard deviation, TPTG—Total triglycerides, VLFC—VLDL free cholesterol, VLPL—VLDL phospholipids, VLTG—VLDL triglycerides, V1CH—VLDL-1 cholesterol, V1FC—VLDL-1 free cholesterol, V1PL—VLDL-1 phospholipids, V1TG—VLDL-1 triglycerides, V5CH—VLDL-5 cholesterol, and V5PL—VLDL-5 phospholipids.

Lipoprotein [g/L]	Con		AD		FC	Unadjusted		Adjusted
	Mean	SD	Mean	SD		p-Value	FDR	p-Value	FDR
H1A2	0.030	0.015	0.041	0.018	0.4	0.02	0.2	0.04	1
H2A2	0.037	0.012	0.043	0.012	0.2	0.03	0.3	0.04	1
IDTG	0.173	0.126	0.122	0.135	−0.3	0.02	0.2	0.95	1
L4TG	0.021	0.009	0.030	0.013	0.4	0.01	0.2	0.2	1
L5TG	0.020	0.011	0.027	0.010	0.3	0.03	0.3	0.2	1
L6TG	0.040	0.016	0.049	0.013	0.2	0.01	0.2	0.07	1
LDTG	0.179	0.043	0.226	0.081	0.3	0.02	0.2	0.3	1
TPTG	1.505	0.672	1.258	0.758	−0.2	0.03	0.3	0.95	1
V1CH	0.084	0.050	0.054	0.051	−0.4	0.002	0.2	0.4	1
V1FC	0.036	0.024	0.022	0.026	−0.4	0.006	0.2	0.5	1
V1PL	0.085	0.053	0.060	0.061	−0.3	0.01	0.2	0.6	1
V1TG	0.550	0.321	0.384	0.402	−0.3	0.005	0.2	0.6	1
V5CH	0.014	0.007	0.010	0.006	−0.3	0.05	0.3	0.3	1
V5PL	0.019	0.006	0.014	0.006	−0.3	0.01	0.2	0.2	1
VLFC	0.100	0.036	0.083	0.044	−0.2	0.04	0.3	0.5	1
VLPL	0.231	0.087	0.196	0.112	−0.1	0.04	0.3	0.8	1
VLTG	0.951	0.498	0.768	0.604	−0.2	0.03	0.3	0.9	1